Member Info for Laura2022

Make that 25% nearly

Also from June 2nd

Securities Purchase Agreement

 

The Company has on 1 June 2025 entered into a securities purchase agreement with the JV Partner (the "Securities Purchase Agreement") with respect to the purchase by the JV Partner of certain shares (the "Shares") of common stock of Mirriad Inc. ("Mirriad U.S."), which represent approximately 19.9% of Mirriad U.S., for an aggregate purchase price of £0.2 million (the "Purchase Price") to be paid in cash by the JV Partner to the Compan

86KB

Good afternoon and very impressive on SCE for u !!

Yes Burt and now PYC are now widely recognised as being at forefront of A.I and personalised medicine £15/20mln wouldn't be an unreasonable minimum

With both taking a stake and with narrow spread of 0.98p - 0.103 it certainly good offer atrade

Pretty sure he was (hopefully) bamned at c 11.00am

Of reappears keep reporting posts AND email

Info@lse.co.uk

EYE looking like stabilis9ng soon

No purchases just yet but I'm tempted

We have one TR1 with 5% and I think KingHomerJ estimated last year that maybe 10-20% are with long term investors

Other A.I stocks which have

"Little or no revenues

"Single or zero client s

Valued at £5-20mln!!

PYC £1 4

Both at 10%

Even then TT it's till below the slightly oversubscribed funding in late Feb which was £500k at 0 5p (and on top of the cash at year end Dec

Therefore, at £1.4mln cap they have nearly £500k cash ( they had £170k at Dec year end) and have won £400k of contracts in last 2mths alone

Multiply that by 12mths ????

The directors CEO have one of lowest salaries on AIM at just £70k versus the £250k average and are winning more contracts per £1mln market cap than 95% of AIM companies

Bobat

Please do an ounce of research

That's for results UP TO Dec 2024

They raised £500k at 0 5p in late Feb 2025

Try again

Kinghomerj

Very good point, NHS are currently aiming to save time ans money with technology that helps

(See last weekend press on blood tests etc)

As you say, the NHS tool/trial we are nearing completion on could be enormous

Good morning

Some excellent days for you on A.I eg CLAI and ALRT

As a comparator both of those are £7mln+ and with all due respect have no revenues as yet

PYC £1.4mln and multiple revenues booked and projected and with global tier 1 and 2 client specification

I think you will do well here

So far after buying at 0.28/29

Well done LSE

His latest ID removed

Please stop disrupting multiple boards such as GEX EYE and now here

You have been banned over 20 times by LSE under 20 different user names

Please report to

Info@lse.co.uk

Sorry Tommy

Wrong again

Just like when I made 100% on other

PYC have won nearly £400,000 in the last2mths alone, against a matketcap of only £1.2mln

Other companies are being valued at x 20 to x50 revenues on AIM in the A.I space

So, recently , we've had our 3rd peer review published in world renowned science journal, a fifth contract in just 2 months and more to come

91 "warm leads" which means discussions taken place

16 active - ( specifc contract focus)

9 at proposal stage ....some with Tier 1 companies